Drugmaker Parabilis Soars 67% After $745 Million IPO, Placement

AI Summary

Parabilis Medicines Inc. raised nearly $745 million in an upsized initial public offering priced above its marketed range, resulting in shares soaring 67% on their trading debut. The strong market reception indicates high investor confidence in the company’s prospects.

Parabilis Medicines Inc. shares jumped as much as 67% in its trading debut, after the company raised nearly $745 million in an upsized US initial public offering that priced above its marketed range and a private placement.